Protalix (PLX) in Focus: Stock Adds 6.5% in Session - Tale of the Tape

Protalix BioTherapeutics, Inc. PLX was a big mover last session with its shares rising over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above the past one month's volatile price range of $3.80 to $4.00.

This biopharmaceutical company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn't been in trend either. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Protalix currently holds a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Some well-placed Bio-Med stocks that warrant a look are ANI Pharmaceuticals, Inc. ANIP, Gilead Sciences Inc. GILD and Illumina Inc. ILMN. All the three stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
PROTALIX BIOTHR PLX: Free Stock Analysis Report
 
ANI PHARMACEUT ANIP: Free Stock Analysis Report
 
GILEAD SCIENCES GILD: Free Stock Analysis Report
 
ILLUMINA INC ILMN: Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversTrading Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!